Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
1.990
0.00 (0.00%)
At close: Jan 17, 2025, 4:00 PM
2.020
+0.030 (1.51%)
After-hours: Jan 17, 2025, 6:56 PM EST
Acelyrin Employees
Acelyrin had 135 employees as of December 31, 2023. The number of employees increased by 88 or 187.23% compared to the previous year.
Employees
135
Change (1Y)
88
Growth (1Y)
187.23%
Revenue / Employee
n/a
Profits / Employee
-$1,958,556
Market Cap
199.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 135 | 88 | 187.23% |
| Dec 31, 2022 | 47 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
SLRN News
- 13 days ago - Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 14 days ago - ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease - GlobeNewsWire
- 18 days ago - ACELYRIN, INC. to Host Virtual Investor Event to Share new Phase 2 Data and Phase 3 Program Design for Subcutaneous Lonigutamab - GlobeNewsWire
- 5 weeks ago - ACELYRIN, INC. Announces Topline Results From Phase 2b/3 Study of Izokibep for the Treatment of Uveitis - GlobeNewsWire
- 2 months ago - Acelyrin, Inc. (SLRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 2 months ago - ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024 - GlobeNewsWire
- 4 months ago - Acelyrin: Straight Move To Phase 3 TED Studies Makes It Must Watch - Seeking Alpha